Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study

Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients

(2019) Vasiliki Nikolaou et al.   SUPPORTIVE CARE IN CANCER

Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer

(2019) Fabrice André et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events

(2019) Heike C. Hawerkamp et al.   ALLERGY

Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients

(2018) Gregory S. Phillips et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Kinase-targeted cancer therapies: progress, challenges and future directions

(2018) Khushwant S. Bhullar et al.   Molecular Cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institutional, retrospective analysis with stratification of reactions by toxicity and implications for management

(2018) Emily Coleman et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Outpatient dermatology consultation impacts the diagnosis and management of pediatric oncology patients: A retrospective study

(2017) Hannah Song et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings

(2017) V. Sibaud et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

(2016) Vincent Sibaud et al.   CURRENT OPINION IN ONCOLOGY

Association of Dermatology Consultation With Accuracy of Cutaneous Disorder Diagnoses in Hospitalized Patients

(2016) Daniela Kroshinsky et al.   JAMA Dermatology

Xerosis and pruritus as major EGFRI-associated adverse events

(2015) Julia M. K. Clabbers et al.   SUPPORTIVE CARE IN CANCER

Experience of a year of adult hospital dermatology consultations

(2014) Eoin R. Storan et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

The Impact of Dermatology Consultation on Diagnostic Accuracy and Antibiotic Use Among Patients With Suspected Cellulitis Seen at Outpatient Internal Medicine Offices

(2014) Ryan Y. Arakaki et al.   JAMA Dermatology

Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic

(2013) Alyx C. Rosen et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Life-threatening dermatologic adverse events in oncology

(2013) Alyx C. Rosen et al.   ANTI-CANCER DRUGS

Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group

(2013) Rebecca K. S. Wong et al.   SUPPORTIVE CARE IN CANCER

Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterization

(2012) Aaron M. Drucker et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

(2012) Alice P. Chen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study

(2012) Emily Y. Chu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib

(2011) IRIS AMITAY-LAISH et al.   Dermatologic Therapy

The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies

(2011) Yevgeniy Balagula et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review

(2011) C. B. Boers-Doets et al.   ONCOLOGIST

Pediatric Dermatology Consultations: A Retrospective Analysis of Inpatient Consultations Referred to the Dermatology Service

(2011) YERAY PEÑATE et al.   PEDIATRIC DERMATOLOGY

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

(2011) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Dermatology inpatient consultations: A retrospective study

(2010) Jacob Bauer et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Risk of Hand-Foot Skin Reaction with the Multitargeted Kinase Inhibitor Sunitinib in Patients with Renal Cell and Non–Renal Cell Carcinoma: A Meta-analysis

(2009) David Chu et al.   Clinical Genitourinary Cancer

Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib

(2008) S. E. Rosenbaum et al.   SUPPORTIVE CARE IN CANCER